Serum microRNAs as diagnostic markers of endometriosis: a comprehensive array-based analysis

To investigate serum microRNAs (miRNAs) in women with endometriosis. Case-control study. University hospital. Women with (n = 24) and without (n = 24) endometriosis. Serum samples were obtained from surgically diagnosed subjects. miRNA from women with without endometriosis were used for microarray p...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Fertility and sterility Ročník 106; číslo 2; s. 402 - 409
Hlavní autoři: Cosar, Emine, Mamillapalli, Ramanaiah, Ersoy, Gulcin Sahin, Cho, SihYun, Seifer, Benjamin, Taylor, Hugh S
Médium: Journal Article
Jazyk:angličtina
Vydáno: United States 01.08.2016
Témata:
ISSN:1556-5653
On-line přístup:Zjistit podrobnosti o přístupu
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
Abstract To investigate serum microRNAs (miRNAs) in women with endometriosis. Case-control study. University hospital. Women with (n = 24) and without (n = 24) endometriosis. Serum samples were obtained from surgically diagnosed subjects. miRNA from women with without endometriosis were used for microarray profiling and confirmed by means of quantitative real-time polymerase chain reaction (qRT-PCR). Receiver operating characteristic (ROC) analysis was performed on differentially expressed miRNAs. miR-3613-5p, miR-6755-3p were down-regulated and miR-125b-5p, miR-150-5p, miR-342-3p, miR-143-3p, miR-145-5p, miR-500a-3p, miR-451a, miR-18a-5p were up-regulated more than 10-fold in the microarray. These results were confirmed with the use of qRT-PCR. Among the differentially expressed miRNAs, miR-125b-5p expression levels had the highest area under the ROC curve (AUC). The maximum AUC score of 1.000 was achieved when combining miR-125b-5p, miR-451a, and miR-3613-5p with the use of a logistic regression model. We identified several miRNAs in serum that distinguished subjects with endometriosis from those without. miR-125b-5p had the greatest potential as a single diagnostic biomarker. A combination of that miRNA with miR-451a and miR-3613-5p further improved diagnostic performance.
AbstractList OBJECTIVETo investigate serum microRNAs (miRNAs) in women with endometriosis.DESIGNCase-control study.SETTINGUniversity hospital.PATIENT(S)Women with (n = 24) and without (n = 24) endometriosis.INTERVENTION(S)Serum samples were obtained from surgically diagnosed subjects.MAIN OUTCOME MEASURE(S)miRNA from women with without endometriosis were used for microarray profiling and confirmed by means of quantitative real-time polymerase chain reaction (qRT-PCR). Receiver operating characteristic (ROC) analysis was performed on differentially expressed miRNAs.RESULT(S)miR-3613-5p, miR-6755-3p were down-regulated and miR-125b-5p, miR-150-5p, miR-342-3p, miR-143-3p, miR-145-5p, miR-500a-3p, miR-451a, miR-18a-5p were up-regulated more than 10-fold in the microarray. These results were confirmed with the use of qRT-PCR. Among the differentially expressed miRNAs, miR-125b-5p expression levels had the highest area under the ROC curve (AUC). The maximum AUC score of 1.000 was achieved when combining miR-125b-5p, miR-451a, and miR-3613-5p with the use of a logistic regression model.CONCLUSION(S)We identified several miRNAs in serum that distinguished subjects with endometriosis from those without. miR-125b-5p had the greatest potential as a single diagnostic biomarker. A combination of that miRNA with miR-451a and miR-3613-5p further improved diagnostic performance.
To investigate serum microRNAs (miRNAs) in women with endometriosis. Case-control study. University hospital. Women with (n = 24) and without (n = 24) endometriosis. Serum samples were obtained from surgically diagnosed subjects. miRNA from women with without endometriosis were used for microarray profiling and confirmed by means of quantitative real-time polymerase chain reaction (qRT-PCR). Receiver operating characteristic (ROC) analysis was performed on differentially expressed miRNAs. miR-3613-5p, miR-6755-3p were down-regulated and miR-125b-5p, miR-150-5p, miR-342-3p, miR-143-3p, miR-145-5p, miR-500a-3p, miR-451a, miR-18a-5p were up-regulated more than 10-fold in the microarray. These results were confirmed with the use of qRT-PCR. Among the differentially expressed miRNAs, miR-125b-5p expression levels had the highest area under the ROC curve (AUC). The maximum AUC score of 1.000 was achieved when combining miR-125b-5p, miR-451a, and miR-3613-5p with the use of a logistic regression model. We identified several miRNAs in serum that distinguished subjects with endometriosis from those without. miR-125b-5p had the greatest potential as a single diagnostic biomarker. A combination of that miRNA with miR-451a and miR-3613-5p further improved diagnostic performance.
Author Taylor, Hugh S
Mamillapalli, Ramanaiah
Cosar, Emine
Ersoy, Gulcin Sahin
Cho, SihYun
Seifer, Benjamin
Author_xml – sequence: 1
  givenname: Emine
  surname: Cosar
  fullname: Cosar, Emine
  organization: Department of Obstetrics, Gynecology, and Reproductive Sciences, Yale School of Medicine, New Haven, Connecticut
– sequence: 2
  givenname: Ramanaiah
  surname: Mamillapalli
  fullname: Mamillapalli, Ramanaiah
  email: ramana.mamillapalli@yale.edu
  organization: Department of Obstetrics, Gynecology, and Reproductive Sciences, Yale School of Medicine, New Haven, Connecticut. Electronic address: ramana.mamillapalli@yale.edu
– sequence: 3
  givenname: Gulcin Sahin
  surname: Ersoy
  fullname: Ersoy, Gulcin Sahin
  organization: Department of Obstetrics, Gynecology, and Reproductive Sciences, Yale School of Medicine, New Haven, Connecticut
– sequence: 4
  givenname: SihYun
  surname: Cho
  fullname: Cho, SihYun
  organization: Department of Obstetrics, Gynecology, and Reproductive Sciences, Yale School of Medicine, New Haven, Connecticut
– sequence: 5
  givenname: Benjamin
  surname: Seifer
  fullname: Seifer, Benjamin
  organization: Department of Obstetrics, Gynecology, and Reproductive Sciences, Yale School of Medicine, New Haven, Connecticut
– sequence: 6
  givenname: Hugh S
  surname: Taylor
  fullname: Taylor, Hugh S
  organization: Department of Obstetrics, Gynecology, and Reproductive Sciences, Yale School of Medicine, New Haven, Connecticut
BackLink https://www.ncbi.nlm.nih.gov/pubmed/27179784$$D View this record in MEDLINE/PubMed
BookMark eNo1kFtLxDAUhIMo7kX_guTRl9akbdrGt2XxBouClzehnCQn2rVN1qQV9t9bcH2ZgeFjYGZBjp13SAjlLOWMl1fb1GIYXBwmTbMpSVmRMp4fkTkXokxEKfIZWcS4ZYyVvMpOySyreCWrupiT9xcMY0_7Vgf__LiKFCI1LXw4H4dW0x7CF4ZIvaXojO9xCK2PbbymQLXvdwE_0cX2BymEAPtEQURDwUG3n6gzcmKhi3h-8CV5u715Xd8nm6e7h_Vqk2hR1UOSZ0orWUiZa5XZUooqB6WswQprBiXjqGrNaptbC2CEgEIYXtUGlRWaQ54tyeVf7y747xHj0PRt1Nh14NCPseE1k0LKohATenFAR9WjaXahnTbum_9Hsl8M-WjH
CitedBy_id crossref_primary_10_1007_s43032_021_00531_4
crossref_primary_10_3389_fendo_2022_1020827
crossref_primary_10_3390_cells11071096
crossref_primary_10_3390_vetsci8060098
crossref_primary_10_1016_j_rbmo_2025_105027
crossref_primary_10_1155_2019_9306803
crossref_primary_10_2147_IJGM_S340629
crossref_primary_10_3390_ijms21051750
crossref_primary_10_1002_ijgo_12521
crossref_primary_10_1038_s41598_025_05719_1
crossref_primary_10_1007_s00404_019_05290_x
crossref_primary_10_3892_etm_2018_7109
crossref_primary_10_1007_s11356_023_31779_9
crossref_primary_10_1038_s41598_017_17956_0
crossref_primary_10_3390_biomedicines12102393
crossref_primary_10_3390_biomedicines12040888
crossref_primary_10_1016_j_neuint_2025_106013
crossref_primary_10_1002_rmb2_12221
crossref_primary_10_3390_biomedicines11113087
crossref_primary_10_3390_diagnostics15050548
crossref_primary_10_1016_j_jri_2025_104459
crossref_primary_10_1038_s41746_022_00638_1
crossref_primary_10_12688_f1000research_22403_1
crossref_primary_10_3390_ijms241915001
crossref_primary_10_1093_humrep_dez116
crossref_primary_10_18502_ijrm_v13i10_7767
crossref_primary_10_1186_s13578_019_0346_3
crossref_primary_10_1155_2022_9957604
crossref_primary_10_3390_ijms26125862
crossref_primary_10_3390_ijms23115862
crossref_primary_10_7759_cureus_54773
crossref_primary_10_1007_s13258_021_01184_y
crossref_primary_10_1093_molehr_gaae044
crossref_primary_10_3390_biom12081144
crossref_primary_10_3390_cancers15010111
crossref_primary_10_1002_mgg3_756
crossref_primary_10_3390_biomedicines10112782
crossref_primary_10_3390_ijms19020599
crossref_primary_10_1177_22840265231210903
crossref_primary_10_1007_s43032_019_00129_x
crossref_primary_10_1002_jcb_28327
crossref_primary_10_1016_j_yexcr_2025_114482
crossref_primary_10_1007_s00404_022_06492_6
crossref_primary_10_1016_j_mce_2023_112040
crossref_primary_10_3390_jcm10132762
crossref_primary_10_1177_1933719117711263
crossref_primary_10_1093_biolre_ioab134
crossref_primary_10_3390_ijms24076116
crossref_primary_10_1177_1933719118765971
crossref_primary_10_1093_biolre_ioy019
crossref_primary_10_1093_biolre_ioy137
crossref_primary_10_3390_biomedicines9111662
crossref_primary_10_1080_09674845_2021_1889157
crossref_primary_10_1002_anbr_202200026
crossref_primary_10_1016_j_jri_2024_104336
crossref_primary_10_1016_j_rbmo_2018_05_007
crossref_primary_10_23946_2500_0764_2023_8_4_24_36
crossref_primary_10_1016_j_prp_2023_154903
crossref_primary_10_3892_ijmm_2024_5344
crossref_primary_10_1080_14737159_2021_1960508
crossref_primary_10_4103_ijmr_IJMR_288_20
crossref_primary_10_1016_j_fertnstert_2019_06_006
crossref_primary_10_1371_journal_pone_0306657
crossref_primary_10_1186_s13048_020_00652_5
crossref_primary_10_1093_hropen_hoac009
crossref_primary_10_3390_jcm8050735
crossref_primary_10_1016_j_fertnstert_2023_12_018
crossref_primary_10_3390_biom15040493
crossref_primary_10_1016_j_rpor_2020_07_006
crossref_primary_10_1210_jc_2017_01199
crossref_primary_10_1016_j_rpor_2020_07_007
crossref_primary_10_1002_2211_5463_12952
crossref_primary_10_3389_fonc_2020_01370
crossref_primary_10_1038_srep43109
crossref_primary_10_1111_cge_12897
crossref_primary_10_1016_j_jogoh_2021_102092
crossref_primary_10_1016_j_ajog_2020_02_050
crossref_primary_10_3390_biomedicines10102558
crossref_primary_10_1016_j_cca_2022_11_013
crossref_primary_10_1002_rmb2_12028
crossref_primary_10_1016_S0140_6736_21_00389_5
crossref_primary_10_1007_s43032_020_00415_z
crossref_primary_10_1016_j_ajog_2018_12_039
crossref_primary_10_1016_j_arr_2018_10_008
crossref_primary_10_1007_s40291_016_0251_y
crossref_primary_10_3390_diagnostics12010175
crossref_primary_10_3390_ijms25031853
crossref_primary_10_3390_biomedicines12102218
crossref_primary_10_1016_j_fertnstert_2020_01_026
crossref_primary_10_1093_humupd_dmy014
crossref_primary_10_1177_1933719116681519
crossref_primary_10_3390_ijms25137177
crossref_primary_10_1007_s00795_020_00252_8
crossref_primary_10_1007_s43032_022_00955_6
crossref_primary_10_1016_j_fertnstert_2017_11_036
crossref_primary_10_1080_20013078_2019_1663666
crossref_primary_10_1016_j_smallrumres_2025_107579
crossref_primary_10_3389_fonc_2024_1329133
crossref_primary_10_1080_15384101_2020_1831254
crossref_primary_10_1080_19396368_2025_2465268
crossref_primary_10_1016_j_intimp_2023_110949
crossref_primary_10_4103_jcrt_JCRT_969_19
crossref_primary_10_3390_ijms24054434
crossref_primary_10_1177_1933719119862050
crossref_primary_10_1186_s12958_023_01181_8
crossref_primary_10_3892_mmr_2024_13167
crossref_primary_10_1007_s10753_023_01862_x
crossref_primary_10_1007_s43032_019_00024_5
crossref_primary_10_1016_j_fertnstert_2019_04_011
crossref_primary_10_1093_biolre_ioz014
crossref_primary_10_2217_pmt_2019_0010
crossref_primary_10_26641_2307_0404_2019_1_162173
crossref_primary_10_1186_s12958_019_0480_0
crossref_primary_10_3390_jcm14144849
crossref_primary_10_1097_RD9_0000000000000073
crossref_primary_10_1016_j_anireprosci_2025_107948
crossref_primary_10_17116_rosakush20252502161
crossref_primary_10_1016_j_genrep_2022_101725
crossref_primary_10_1210_jc_2018_01464
crossref_primary_10_1096_fj_201801711R
crossref_primary_10_3390_ijms221910498
crossref_primary_10_1155_2021_1328682
crossref_primary_10_1158_1078_0432_CCR_17_0996
crossref_primary_10_1016_j_repbio_2021_100592
crossref_primary_10_1007_s11033_024_09357_0
crossref_primary_10_1016_j_repbio_2023_100796
crossref_primary_10_1080_13697137_2019_1578743
crossref_primary_10_1007_s00795_021_00303_8
crossref_primary_10_1016_j_fertnstert_2017_09_005
crossref_primary_10_1186_s13046_017_0568_3
ContentType Journal Article
Copyright Copyright © 2016 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.
Copyright_xml – notice: Copyright © 2016 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.
DBID CGR
CUY
CVF
ECM
EIF
NPM
7U8
7X8
C1K
JXQ
DOI 10.1016/j.fertnstert.2016.04.013
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
TOXLINE
MEDLINE - Academic
Environmental Sciences and Pollution Management
Toxline
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
TOXLINE
MEDLINE - Academic
Environmental Sciences and Pollution Management
DatabaseTitleList TOXLINE
MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: 7X8
  name: MEDLINE - Academic
  url: https://search.proquest.com/medline
  sourceTypes: Aggregation Database
DeliveryMethod no_fulltext_linktorsrc
Discipline Medicine
EISSN 1556-5653
EndPage 409
ExternalDocumentID 27179784
Genre Multicenter Study
Journal Article
GrantInformation_xml – fundername: NICHD NIH HHS
  grantid: R01 HD076422
GroupedDBID ---
--K
-~X
.1-
.55
.FO
.GJ
0R~
1B1
1P~
1~5
29H
34R
3O-
4.4
457
4G.
53G
5GY
5RE
5VS
7-5
71M
85S
AAEDT
AAEDW
AAFWJ
AALRI
AAQFI
AAQXK
AAXUO
AAYWO
ABCQX
ABFRF
ABJNI
ABLJU
ABMAC
ABWVN
ACGFO
ACIUM
ACRPL
ACVFH
ADBBV
ADCNI
ADMUD
ADNMO
ADVLN
AEFWE
AENEX
AEUPX
AEVXI
AFCTW
AFFNX
AFJKZ
AFPUW
AFRHN
AFTJW
AGCQF
AGQPQ
AI.
AIGII
AITUG
AJUYK
AKBMS
AKRWK
AKYEP
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
APXCP
ASPBG
AVWKF
AZFZN
BELOY
C5W
CGR
CS3
CUY
CVF
DU5
EBS
ECM
EFJIC
EFKBS
EIF
EJD
F5P
FDB
FEDTE
FGOYB
GBLVA
HVGLF
HZ~
IHE
J1W
J5H
K-O
KOM
L7B
M41
MO0
N9A
NPM
NQ-
O9-
OK1
OQ.
P2P
PH~
R2-
RIG
ROL
RPZ
SDP
SEL
SES
SEW
SSZ
UNMZH
UV1
VH1
W2D
X7M
XH2
XJT
XPP
YOC
YZZ
Z5R
ZGI
ZXP
~S-
7U8
7X8
C1K
JXQ
ID FETCH-LOGICAL-c578t-32bcb94993cb2f69573abbfde7e80a601eb8c08f3ffaad55a45d178debf5c1a32
IEDL.DBID 7X8
ISICitedReferencesCount 158
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000380763400031&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
IngestDate Sun Sep 28 10:53:58 EDT 2025
Mon Jul 21 06:03:22 EDT 2025
IsPeerReviewed true
IsScholarly true
Issue 2
Keywords Endometriosis
miRNA
microarray
biomarker
serum
Language English
License Copyright © 2016 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c578t-32bcb94993cb2f69573abbfde7e80a601eb8c08f3ffaad55a45d178debf5c1a32
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
PMID 27179784
PQID 1809599445
PQPubID 23479
PageCount 8
ParticipantIDs proquest_miscellaneous_1809599445
pubmed_primary_27179784
PublicationCentury 2000
PublicationDate 2016-08-01
PublicationDateYYYYMMDD 2016-08-01
PublicationDate_xml – month: 08
  year: 2016
  text: 2016-08-01
  day: 01
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Fertility and sterility
PublicationTitleAlternate Fertil Steril
PublicationYear 2016
SSID ssj0006172
Score 2.566142
Snippet To investigate serum microRNAs (miRNAs) in women with endometriosis. Case-control study. University hospital. Women with (n = 24) and without (n = 24)...
OBJECTIVETo investigate serum microRNAs (miRNAs) in women with endometriosis.DESIGNCase-control study.SETTINGUniversity hospital.PATIENT(S)Women with (n = 24)...
SourceID proquest
pubmed
SourceType Aggregation Database
Index Database
StartPage 402
SubjectTerms Adult
Area Under Curve
Case-Control Studies
Connecticut
Endometriosis - blood
Endometriosis - diagnosis
Endometriosis - genetics
Female
Gene Expression Profiling - methods
Genetic Markers
Genetic Predisposition to Disease
Hospitals, University
Humans
Logistic Models
MicroRNAs - blood
MicroRNAs - genetics
Oligonucleotide Array Sequence Analysis
Phenotype
Predictive Value of Tests
Real-Time Polymerase Chain Reaction
Reproducibility of Results
ROC Curve
Seoul
Title Serum microRNAs as diagnostic markers of endometriosis: a comprehensive array-based analysis
URI https://www.ncbi.nlm.nih.gov/pubmed/27179784
https://www.proquest.com/docview/1809599445
Volume 106
WOSCitedRecordID wos000380763400031&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText
inHoldings 1
isFullTextHit
isPrint
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3LS8MwGA_qRLz4fswXEbwGa5OsjRcZ4vDgyhCVHYSSJ-7Qdrab4H9vvrZjJ0HwklsgfPnyvfLj90PoSkhgWBE--ilKCeOOEcEVJ5r1tIJRg63lgN6eoiSJx2MxagduVQurXMTEOlCbQsOM_Bp4prgQjPG76ScB1Sj4XW0lNFZRh_pSBrw6Gi_ZwiE7t-idBtPlbAnErH4FUFevJjkFYYPfiss6yQy2_3u8HbTVlpe43_jDLlqx-R7aGLYf6Pvo3ceGeYYzgOE9J_0KywqbBm3nd-AMwDplhQuHbW6KDOS2impS3WKJAXxe2o8G8I5lWcpvAjnQYNkSmxyg18HDy_0jaQUWiPYPdUZoqPyF-J6HahW6nuARlUo5YyMbB9K3albFOogddU5Kw7lk3NxEsbHKcX0jaXiI1vIit8cIc6G5lDE3zHJWtymUSW4DHRgTGRt00eXCbql3YPiVkLkt5lW6tFwXHTXGT6cN00Ya-mbTOww7-cPuU7QJd9qA885Qx_nna8_Ruv6aTaryovYMvyaj4Q8qBcdd
linkProvider ProQuest
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Serum+microRNAs+as+diagnostic+markers+of+endometriosis%3A+a+comprehensive+array-based+analysis&rft.jtitle=Fertility+and+sterility&rft.au=Cosar%2C+Emine&rft.au=Mamillapalli%2C+Ramanaiah&rft.au=Ersoy%2C+Gulcin+Sahin&rft.au=Cho%2C+SihYun&rft.date=2016-08-01&rft.eissn=1556-5653&rft.volume=106&rft.issue=2&rft.spage=402&rft.epage=409&rft_id=info:doi/10.1016%2Fj.fertnstert.2016.04.013&rft.externalDBID=NO_FULL_TEXT